ARTICLE | Clinical News
PeramiFlu peramivir regulatory update
August 23, 2010 7:00 AM UTC
BioCryst said partner Green Cross received South Korean marketing approval for IV PeramiFlu peramivir to treat influenza A & B viruses, including pandemic H1N1 and avian flu. Green Cross, which has So...